Cargando…

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control

Detalles Bibliográficos
Autores principales:	Chen, Jian, Su, Zhaoliang, Wang, Guangchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603049/ https://www.ncbi.nlm.nih.gov/pubmed/37884533 http://dx.doi.org/10.1038/s41392-023-01664-5

Ejemplares similares

Dietary intervention, a promising adjunct for cancer therapy
por: Shi, Rongchen, et al.
Publicado: (2020)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming
por: Su, Xinming, et al.
Publicado: (2023)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation
por: Vu Manh, Thien-Phong, et al.
Publicado: (2013)

Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
por: Wang, Yunguang, et al.
Publicado: (2021)

Dark side of cyanobacteria: searching for strategies to control blooms
por: Huertas, María José, et al.
Publicado: (2021)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer
por: Mi, Mi, et al.
Publicado: (2022)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Microbes are off the menu: Defective macrophage phagocytosis in COPD
por: Walton, Emma Louise
Publicado: (2017)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells
por: Almeida, Luís, et al.
Publicado: (2021)

microRNAs become macro players in somatic cell reprogramming
por: Onder, Tamer T, et al.
Publicado: (2011)

Macrophages assemble! But do they need IL‐4R during schistosomiasis?
por: Rückerl, Dominik, et al.
Publicado: (2019)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Proteomics promises a new era of precision cancer medicine
por: Wu, Chong, et al.
Publicado: (2019)

Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
por: Ling, Yan, et al.
Publicado: (2022)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
por: Weiskirchen, Ralf
Publicado: (2023)

Competition for nutrients or cell intrinsic programming? – Metabolic mechanisms behind the tumor promoting immune microenvironment in cancer
por: Niu, Yuequn, et al.
Publicado: (2021)

OSKM-mediated reversible reprogramming of cardiomyocytes regenerates injured myocardium
por: Farber, Gregory, et al.
Publicado: (2022)

Target competition: transcription factors enter the limelight
por: Karreth, Florian A, et al.
Publicado: (2014)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

Promising biotechnological applications of antibiofilm exopolysaccharides
por: Bernal, Patricia, et al.
Publicado: (2012)

Beyond natural targets: chemical synthesis reprograms the target specificity of rapamycin
por: Zhang, Ziyang
Publicado: (2022)

Immune receptor mimicking hormone receptors: a new guarding strategy
por: Liu, Xueru, et al.
Publicado: (2023)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers
por: Xu, Rongyang, et al.
Publicado: (2023)

Induction of membraneless organelles as a strategy for HIV-1 post-nuclear entry steps
por: Zhou, Sheng, et al.
Publicado: (2023)

Cancer cell reprogramming: a promising therapy converting malignancy to benignity
por: Gong, Lanqi, et al.
Publicado: (2019)

A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation
por: Jurgens, Anouk P., et al.
Publicado: (2021)

Surrogate cytokine agonists: promising agents against COVID-19
por: Lin, Zemin, et al.
Publicado: (2022)

Organoid-based chemical approach to dissect the mechanism controlling cellular dynamics
por: Lacko, Lauretta A, et al.
Publicado: (2019)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_04g3sdbh5bpugg5ucha7t44kut